Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: E9AYB0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.327 |
CLV_NRD_NRD_1 | 14 | 16 | PF00675 | 0.475 |
CLV_NRD_NRD_1 | 306 | 308 | PF00675 | 0.425 |
CLV_NRD_NRD_1 | 321 | 323 | PF00675 | 0.293 |
CLV_NRD_NRD_1 | 54 | 56 | PF00675 | 0.410 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.432 |
CLV_PCSK_KEX2_1 | 110 | 112 | PF00082 | 0.392 |
CLV_PCSK_KEX2_1 | 306 | 308 | PF00082 | 0.431 |
CLV_PCSK_KEX2_1 | 321 | 323 | PF00082 | 0.293 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.481 |
CLV_PCSK_SKI1_1 | 170 | 174 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 243 | 247 | PF00082 | 0.316 |
CLV_PCSK_SKI1_1 | 306 | 310 | PF00082 | 0.368 |
DEG_APCC_DBOX_1 | 227 | 235 | PF00400 | 0.341 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.721 |
DOC_CYCLIN_RxL_1 | 237 | 247 | PF00134 | 0.337 |
DOC_CYCLIN_RxL_1 | 32 | 43 | PF00134 | 0.609 |
DOC_CYCLIN_RxL_1 | 4 | 14 | PF00134 | 0.707 |
DOC_MAPK_gen_1 | 306 | 315 | PF00069 | 0.691 |
DOC_MAPK_MEF2A_6 | 146 | 155 | PF00069 | 0.666 |
DOC_MAPK_MEF2A_6 | 327 | 335 | PF00069 | 0.322 |
DOC_PP1_RVXF_1 | 196 | 203 | PF00149 | 0.472 |
DOC_PP1_RVXF_1 | 241 | 247 | PF00149 | 0.330 |
DOC_PP2B_LxvP_1 | 239 | 242 | PF13499 | 0.357 |
DOC_PP2B_LxvP_1 | 67 | 70 | PF13499 | 0.678 |
DOC_USP7_UBL2_3 | 97 | 101 | PF12436 | 0.610 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.695 |
LIG_14-3-3_CanoR_1 | 181 | 189 | PF00244 | 0.625 |
LIG_14-3-3_CanoR_1 | 321 | 325 | PF00244 | 0.501 |
LIG_Actin_WH2_2 | 216 | 234 | PF00022 | 0.469 |
LIG_BIR_III_2 | 298 | 302 | PF00653 | 0.606 |
LIG_eIF4E_1 | 251 | 257 | PF01652 | 0.326 |
LIG_FHA_1 | 182 | 188 | PF00498 | 0.627 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.728 |
LIG_FHA_1 | 324 | 330 | PF00498 | 0.433 |
LIG_FHA_2 | 315 | 321 | PF00498 | 0.577 |
LIG_LIR_Gen_1 | 323 | 333 | PF02991 | 0.383 |
LIG_LIR_Nem_3 | 194 | 200 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 24 | 30 | PF02991 | 0.603 |
LIG_LIR_Nem_3 | 272 | 278 | PF02991 | 0.537 |
LIG_LIR_Nem_3 | 31 | 36 | PF02991 | 0.656 |
LIG_LIR_Nem_3 | 323 | 328 | PF02991 | 0.383 |
LIG_NRBOX | 328 | 334 | PF00104 | 0.315 |
LIG_PCNA_PIPBox_1 | 20 | 29 | PF02747 | 0.605 |
LIG_SH2_CRK | 197 | 201 | PF00017 | 0.454 |
LIG_SH2_CRK | 33 | 37 | PF00017 | 0.690 |
LIG_SH2_STAP1 | 183 | 187 | PF00017 | 0.581 |
LIG_SH2_STAT3 | 183 | 186 | PF00017 | 0.645 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.585 |
LIG_SH2_STAT5 | 2 | 5 | PF00017 | 0.687 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 216 | 219 | PF00017 | 0.399 |
LIG_SH3_3 | 150 | 156 | PF00018 | 0.712 |
LIG_SH3_3 | 220 | 226 | PF00018 | 0.453 |
LIG_SH3_3 | 260 | 266 | PF00018 | 0.565 |
LIG_SUMO_SIM_par_1 | 331 | 337 | PF11976 | 0.292 |
LIG_TYR_ITIM | 195 | 200 | PF00017 | 0.631 |
LIG_UBA3_1 | 172 | 176 | PF00899 | 0.634 |
LIG_UBA3_1 | 8 | 16 | PF00899 | 0.713 |
MOD_CDK_SPxxK_3 | 3 | 10 | PF00069 | 0.697 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.703 |
MOD_CK1_1 | 72 | 78 | PF00069 | 0.682 |
MOD_CK1_1 | 80 | 86 | PF00069 | 0.627 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.689 |
MOD_CK2_1 | 314 | 320 | PF00069 | 0.635 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.488 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.553 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.341 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.442 |
MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.475 |
MOD_GlcNHglycan | 81 | 85 | PF01048 | 0.388 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.596 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.682 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.614 |
MOD_NEK2_1 | 244 | 249 | PF00069 | 0.290 |
MOD_NEK2_1 | 256 | 261 | PF00069 | 0.412 |
MOD_PIKK_1 | 175 | 181 | PF00454 | 0.619 |
MOD_PIKK_1 | 182 | 188 | PF00454 | 0.593 |
MOD_PKA_2 | 130 | 136 | PF00069 | 0.511 |
MOD_PKA_2 | 187 | 193 | PF00069 | 0.602 |
MOD_PKA_2 | 320 | 326 | PF00069 | 0.453 |
MOD_Plk_2-3 | 18 | 24 | PF00069 | 0.689 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.695 |
MOD_Plk_4 | 191 | 197 | PF00069 | 0.583 |
MOD_Plk_4 | 207 | 213 | PF00069 | 0.419 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.607 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.696 |
TRG_AP2beta_CARGO_1 | 24 | 34 | PF09066 | 0.591 |
TRG_DiLeu_BaLyEn_6 | 240 | 245 | PF01217 | 0.442 |
TRG_DiLeu_BaLyEn_6 | 4 | 9 | PF01217 | 0.696 |
TRG_ENDOCYTIC_2 | 197 | 200 | PF00928 | 0.551 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.323 |
TRG_ENDOCYTIC_2 | 216 | 219 | PF00928 | 0.399 |
TRG_ENDOCYTIC_2 | 251 | 254 | PF00928 | 0.326 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.690 |
TRG_ER_diArg_1 | 110 | 112 | PF00400 | 0.638 |
TRG_ER_diArg_1 | 306 | 308 | PF00400 | 0.550 |
TRG_Pf-PMV_PEXEL_1 | 306 | 310 | PF00026 | 0.421 |
TRG_Pf-PMV_PEXEL_1 | 38 | 43 | PF00026 | 0.368 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2V8 | Leptomonas seymouri | 72% | 96% |
A0A0S4KIA3 | Bodo saltans | 34% | 100% |
A0A1X0NS63 | Trypanosomatidae | 47% | 93% |
A0A3R7M7G1 | Trypanosoma rangeli | 51% | 100% |
A0A3S7WZZ7 | Leishmania donovani | 97% | 100% |
A4HEY6 | Leishmania braziliensis | 89% | 100% |
A4I260 | Leishmania infantum | 97% | 100% |
C9ZRU1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
Q4Q963 | Leishmania major | 96% | 100% |
V5B9S2 | Trypanosoma cruzi | 49% | 99% |